COGT logo

Cogent Biosciences, Inc. (COGT) EBITDA

Annual EBITDA:

-$271.59M-$67.05M(-32.78%)
December 31, 2024

Summary

  • As of today, COGT annual EBITDA is -$271.59 million, with the most recent change of -$67.05 million (-32.78%) on December 31, 2024.
  • During the last 3 years, COGT annual EBITDA has fallen by -$198.03 million (-269.21%).
  • COGT annual EBITDA is now -4134.96% below its all-time high of -$6.41 million, reached on December 31, 2015.

Performance

COGT EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOGTincome statement metrics

Quarterly EBITDA:

-$72.06M+$1.74M(+2.35%)
June 30, 2025

Summary

  • As of today, COGT quarterly EBITDA is -$72.06 million, with the most recent change of +$1.74 million (+2.35%) on June 30, 2025.
  • Over the past year, COGT quarterly EBITDA has dropped by -$14.19 million (-24.52%).
  • COGT quarterly EBITDA is now -2921.38% below its all-time high of $2.55 million, reached on December 31, 2019.

Performance

COGT Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOGTincome statement metrics

TTM EBITDA:

-$292.80M-$14.19M(-5.09%)
June 30, 2025

Summary

  • As of today, COGT TTM EBITDA is -$292.80 million, with the most recent change of -$14.19 million (-5.09%) on June 30, 2025.
  • Over the past year, COGT TTM EBITDA has dropped by -$57.43 million (-24.40%).
  • COGT TTM EBITDA is now -4956.05% below its all-time high of -$5.79 million, reached on March 31, 2017.

Performance

COGT TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOGTincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

COGT EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-32.8%-24.5%-24.4%
3Y3 Years-269.2%-104.8%-165.1%
5Y5 Years-779.4%-912.5%-1323.0%

COGT EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-269.2%at low-117.6%+3.0%-135.7%at low
5Y5-Year-779.4%at low-608.7%+3.0%-1323.0%at low
All-TimeAll-Time-4135.0%at low-2921.4%+3.0%-4956.1%at low

COGT EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
-$72.06M(+2.4%)
-$292.80M(-5.1%)
Mar 2025
-
-$73.80M(-1.6%)
-$278.61M(-4.7%)
Dec 2024
-$271.59M(-32.8%)
-$72.63M(+2.3%)
-$266.15M(-6.1%)
Sep 2024
-
-$74.32M(-28.4%)
-$250.96M(-6.6%)
Jun 2024
-
-$57.87M(+5.7%)
-$235.37M(-5.4%)
Mar 2024
-
-$61.34M(-6.8%)
-$223.37M(-9.2%)
Dec 2023
-$204.54M(-44.1%)
-$57.43M(+2.2%)
-$204.54M(-7.7%)
Sep 2023
-
-$58.73M(-28.0%)
-$189.92M(-15.6%)
Jun 2023
-
-$45.87M(-7.9%)
-$164.30M(-7.0%)
Mar 2023
-
-$42.51M(+0.7%)
-$153.62M(-8.2%)
Dec 2022
-$141.96M(-93.0%)
-$42.81M(-29.3%)
-$141.96M(-14.3%)
Sep 2022
-
-$33.11M(+5.9%)
-$124.25M(-12.5%)
Jun 2022
-
-$35.19M(-14.0%)
-$110.44M(-20.5%)
Mar 2022
-
-$30.86M(-23.0%)
-$91.64M(-24.6%)
Dec 2021
-$73.56M(-112.8%)
-$25.09M(-30.0%)
-$73.56M(-22.8%)
Sep 2021
-
-$19.30M(-17.9%)
-$59.91M(-18.0%)
Jun 2021
-
-$16.38M(-28.1%)
-$50.77M(-22.3%)
Mar 2021
-
-$12.78M(-11.7%)
-$41.51M(-20.1%)
DateAnnualQuarterlyTTM
Dec 2020
-$34.57M(-11.9%)
-$11.44M(-12.5%)
-$34.57M(-68.0%)
Sep 2020
-
-$10.17M(-42.9%)
-$20.58M(+7.0%)
Jun 2020
-
-$7.12M(-21.7%)
-$22.13M(+12.3%)
Mar 2020
-
-$5.85M(-328.9%)
-$25.22M(+18.3%)
Dec 2019
-$30.89M(+11.0%)
$2.55M(+121.8%)
-$30.89M(+26.6%)
Sep 2019
-
-$11.72M(-14.8%)
-$42.09M(-3.6%)
Jun 2019
-
-$10.21M(+11.3%)
-$40.62M(-2.8%)
Mar 2019
-
-$11.51M(-33.0%)
-$39.52M(-14.0%)
Dec 2018
-$34.68M(-38.8%)
-$8.65M(+15.6%)
-$34.68M(-6.4%)
Sep 2018
-
-$10.25M(-12.4%)
-$32.60M(-11.6%)
Jun 2018
-
-$9.11M(-36.6%)
-$29.23M(-13.0%)
Mar 2018
-
-$6.67M(-1.5%)
-$25.86M(-3.5%)
Dec 2017
-$24.98M(-37.0%)
-$6.57M(+4.3%)
-$24.98M(-35.7%)
Sep 2017
-
-$6.87M(-19.5%)
-$18.41M(-59.5%)
Jun 2017
-
-$5.75M(+0.8%)
-$11.54M(-99.2%)
Mar 2017
-
-$5.79M
-$5.79M
Dec 2016
-$18.24M(-184.4%)
-
-
Dec 2015
-$6.41M
-
-

FAQ

  • What is Cogent Biosciences, Inc. annual EBITDA?
  • What is the all-time high annual EBITDA for Cogent Biosciences, Inc.?
  • What is Cogent Biosciences, Inc. annual EBITDA year-on-year change?
  • What is Cogent Biosciences, Inc. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Cogent Biosciences, Inc.?
  • What is Cogent Biosciences, Inc. quarterly EBITDA year-on-year change?
  • What is Cogent Biosciences, Inc. TTM EBITDA?
  • What is the all-time high TTM EBITDA for Cogent Biosciences, Inc.?
  • What is Cogent Biosciences, Inc. TTM EBITDA year-on-year change?

What is Cogent Biosciences, Inc. annual EBITDA?

The current annual EBITDA of COGT is -$271.59M

What is the all-time high annual EBITDA for Cogent Biosciences, Inc.?

Cogent Biosciences, Inc. all-time high annual EBITDA is -$6.41M

What is Cogent Biosciences, Inc. annual EBITDA year-on-year change?

Over the past year, COGT annual EBITDA has changed by -$67.05M (-32.78%)

What is Cogent Biosciences, Inc. quarterly EBITDA?

The current quarterly EBITDA of COGT is -$72.06M

What is the all-time high quarterly EBITDA for Cogent Biosciences, Inc.?

Cogent Biosciences, Inc. all-time high quarterly EBITDA is $2.55M

What is Cogent Biosciences, Inc. quarterly EBITDA year-on-year change?

Over the past year, COGT quarterly EBITDA has changed by -$14.19M (-24.52%)

What is Cogent Biosciences, Inc. TTM EBITDA?

The current TTM EBITDA of COGT is -$292.80M

What is the all-time high TTM EBITDA for Cogent Biosciences, Inc.?

Cogent Biosciences, Inc. all-time high TTM EBITDA is -$5.79M

What is Cogent Biosciences, Inc. TTM EBITDA year-on-year change?

Over the past year, COGT TTM EBITDA has changed by -$57.43M (-24.40%)
On this page